Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease

European Heart Journal Cardiovascular Imaging

Volumn 14, Issue 1, 2013, Pages 43-50

  Matsuo, Yoshiki ^a   Kubo, Takashi ^a   Okumoto, Yasushi ^a   Ishibashi, Kohei ^b   Komukai, Kenichi ^b   Tanimoto, Takashi ^b   Ino, Yasushi ^b   Kitabata, Hironori ^b   Hirata, Kumiko ^b   Imanishi, Toshio ^b   Akagi, Hideharu ^a   Akasaka, Takashi ^b  

^a Social Insurance Kinan Hospital   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Optical coherence tomography; Oxidized low density lipoprotein; Vulnerable plaque

Indexed keywords

LOW DENSITY LIPOPROTEIN; MALONDIALDEHYDE MODIFIED LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; THIN CAP FIBROATHEROMA;

ACUTE CORONARY SYNDROME; AGED; ALGORITHMS; ANGINA PECTORIS; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; FEASIBILITY STUDIES; FEMALE; HUMANS; LIPOPROTEINS, LDL; LOGISTIC MODELS; MALE; MALONDIALDEHYDE; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84871194644     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jes094     Document Type: Article

References (31)

1. Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol 2007;27:15-26.
2. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998;98:1487-94.
3. Holvoet P, Collen D, Van de Werf F. Malondialdehyde-modified LDL as a marker of acute coronary syndromes. J Am Med Assoc 1999;281:1718-21.
4. Toshima S, Hasegawa A, Kurabayashi M, Itabe H, Takano T, Sugano J et al. Circulating oxidized low density lipoprotein levels: a biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 2000;20:2243-7.
5. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001;103:1955-60.
6. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 2007;50:933-9.
7. Tanaka A, Imanishi T, Kitabata H, Kubo T, Takarada S, Kataiwa H et al. Distribution and frequency of thin-capped fibroatheromas and ruptured plaques in the entire culprit coronary artery in patients with acute coronary syndrome as determined by optical coherence tomography. Am J Cardiol 2008;102:975-9.
8. Mizukoshi M, Imanishi T, Tanaka A, Kubo T, Liu Y, Takarada S et al. Clinical classification and plaque morphology determined by optical coherence tomography in unstable angina pectoris. Am J Cardiol 2010;106:323-8.
9. Akasaka T, Kubo T, Mizukoshi M, Tanaka A, Kitabata H, Tanimoto T et al. Pathophysiology of acute coronary syndrome assessed by optical coherence tomography. J Cardiol 2010;56:8-514.
10. Kubo T, Imanishi T, Kashiwagi M, Ikejima H, Tsujioka H, Kuroi A et al. Multiple coronary lesion instability in patients with acute myocardial infarction as determined by optical coherence tomography. Am J Cardiol 2010;105:318-22.
11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
12. Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M et al. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome] study). J Am Coll Cardiol 2009;54:293-302.
13. Tanaga K, Bujo H, Inoue M, Mikami K, Kotani K, Takahashi K et al. Increased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles. Arterioscler Thromb Vasc Biol 2002;22:662-6.
14. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003;108:1664-72.
15. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-75.
16. Kume T, Akasaka T, Kawamoto T, Okura H, Watanabe N, Toyota Eet al. Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J 2006;152:755.e1-4.
17. Huang Y, Mironova M, Lopes-Virella MF. Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells. Arterioscler Thromb Vasc Biol 1999;19:2640-47.
18. Xu XP, Meisel SR, Ong JM, Kaul S, Cercek B, Rajavashisth TB et al. Oxidized lowdensity lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation 1999;99:993-8.
19. Li D, Liu L, Chen H, Sawamura T, Ranganathan S, Mehta JL. LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells. Circulation 2003;107:612-7.
20. Holvoet P, Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J 1994;8:1279-84.
21. Kato R, Mori C, Kitazato K, Arata S, Obama T, Mori M et al. Transient increase in plasma oxidized LDL during the progression of atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2009;29:33-9.
22. Tsimikas S, Lau HK, Han KR, Shortal B, Miller ER, Segev A et al. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein (a): short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation 2004;109:3164-70.
23. Ferrante G, Nakano M, Prati F, Niccoli G, Mallus MT, Ramazzotti V et al. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study. Circulation 2010;122:2505-13.
24. Carr AC, McCall MR, Frei B. Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arterioscler Thromb Vasc Biol 2000;20:1716-23.
25. De Servi S, Mariani M, Mariani G, Mazzone A. C-reactive protein increase in unstable coronary disease cause or effect? J Am Coll Cardiol 2005;46:1496-502.
26. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB et al. The prognostic value of C-reactive protein and serum amyloid: a protein in severe unstable angina. N Engl J Med 1994;331:417-24.
27. Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y et al. Highsensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler Thromb Vasc Biol 2008; 28:1385-91.
28. Shimada K, Fujita M, Tanaka A, Yoshida K, Jisso S, Tanaka H et al. Elevated serum C-reactive protein levels predict cardiovascular events in the Japanese coronary artery disease (JCAD) study. Circ J 2009;73:78-85.
29. Momiyama Y, Kawaguchi A, Kajiwara I, Ohmori R, Okada K, Saito I et al. Prognostic value of plasma high-sensitivity C-reactive protein levels in Japanese patients with stable coronary artery disease: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) Study. Atherosclerosis 2009;207:272-6.
30. Tsimikas S, Bergmark C, Beyer RW, Patel R, Pattison J, Miller E et al. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol 2003;41: 360-70.
31. Naruko T, Ueda M, Ehara S, Itoh A, Haze K, Shirai N et al. Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis. Arterioscler Thromb Vasc Biol 2006;26:877-83.